About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Migraine Clinical Trials | 1,816 Studies Recruiting

Clinical TrialsMigraine

Migraine Clinical Trials

Browse 1,816 clinical trials for migraine. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1321-1340 of 1,816 trials

WithdrawnCefaliv® Compared to Neosaldina® in the Treatment of Migraine AttacksThis study evaluates the non-inferiority of Cefaliv® compared to Neosaldina® in the treatment of migraine attack in two hundred and sixteen adults of both sexes with age between…NCT02706015·Guarulhos, São Paulo Active not recruitingYogabased Movements for Primary Headaches (Migraine and/or Cluster Headache) - YOURHEAD - a Pilot StudyMigraine and/or Cluster Headache: Study Overview \*\*Background:\*\* Migraine and cluster headache are two primary headache disorders that significantly impact quality of life…NCT07292090·Huddinge

Related Searches

Data from ClinicalTrials.govTerms

CompletedAcetazolamide's Headache Inducing Characteristics and Effects on the Cerebral Arteries and Blood FlowIn this study the investigators will research the hypothesis that the drug Acetazolamide induce headache and dilation of cerebral arteries and increase the cerebral blood flow in…NCT01750723·Copenhagen, Glostrup and 1 other

RecruitingClosed-loop RTMS for Short-term Migraine PreventionMigraine is a prevalent and debilitating primary headache disorder, where patients suffer from disabling symptoms that usually consist of a moderate to severe headache lasting 4…NCT06735768·Vienna, State of Vienna

UnknownVolumetric MRI Brain in Patients With MigraineAssessment of the role of volumetric MRI in evaluation of different types of migraine .NCT06077448

CompletedMEDUSA Study - Migraine: Evaluation of Diagnosis, Utilisation of Services and ApplicationMigraine is a very common condition characterised by frequent severe headaches that are very debilitating.NCT05979285·Carlisle, Cumbria

Active not recruitingMulticenter, Double-blind, and Randomized Controlled Trial of Ultra-Distal TENS Device for Migraine TreatmentMulticenter, double-blind, and randomized controlled trial of Ultra-Distal Transcutaneous Electrical Nerve Stimulation (TENS) Device for Migraine treatment.NCT07451158·Hangzhou, Zhejiang

UnknownInvestigation of Functional Brain Features in Women with MigraineThis study aims to investigate whether the functional alterations in the brain of individuals with migraine appear before the peripheral vascular changes.NCT06470958·Glostrup Municipality

CompletedObservational Prospective Study on the Presence of Typical Migraine Features in Nummular Headache Patients: The Numamig StudyObservational analytic study with prospective cohort design that aim to describe the presence of typical features of migraine in a cohort of nummular headache patients.NCT04299958·Valladolid

CompletedEfficacy and Safety Study of Rimegepant for Migraine Prevention in Japanese Subjects (Japan Only)This study is being conducted to evaluate the efficacy, safety, and tolerability of rimegepant in Japanese subjects for the prevention of migraine.NCT05399485·Matsuyama, Ehime and 43 others

CompletedEfficacy of Fascia Exercises in Migraine PatientsMigraine, which is characterized by attacks and many accompanying symptoms, negatively affects the quality of life of patients.NCT06231615·Ankara, Çubuk

UnknownOpen Label, 6-month Study for High Frequency and Chronic Migraine,This is a prospective, multi-center, unblinded study in patients with migraine (≥ 8 MMDs/month) requiring preventive treatment.NCT06133491·Los Angeles, California and 1 other

CompletedA Study of LY2951742 in Participants With MigraineTo assess the efficacy and safety of LY2951742 in the prevention of migraine headache in migraineurs with or without aura during 3 months of treatment.NCT01625988·Gilbert, Arizona and 36 others

CompletedThe RIME Study - Combined Occipital and Supraorbital Transcutaneous Nerve Stimulation for Treatment of Migrainethis study will evaluate the clinical performance and safety of a self administered abortive treatment for migraine headache using combined occipital and supraorbital…NCT03631550·Tempe, Arizona and 11 others

UnknownThe Functional Magnetic Resonance Imaging Study on the Processing of Acute Pain and Cognition Among Perimenopause WomenThere lacks effective early screen system for the migraine-susceptible women during the peri-menopause period.NCT02820974

CompletedEfficacy and Safety Trial of BHV-2100 for the Acute Treatment of MigraineThis study is designed to identify at least one dose of BHV-2100 that is safe and effective in reducing headache pain and other symptoms in the treatment of migraine.NCT06603623·Gilbert, Arizona and 59 others

CompletedBI 44370 TA in Acute Migraine AttackThe objective of this trial is to assess the safety, tolerability, and efficacy of three doses of BI 44370 TA in the treatment of patients with an acute migraine attack and…NCT00751803·Antwerp and 51 others

TerminatedChordate System S020 Acute Migraine Clinical InvestigationThe main purpose of the study is to evaluate the impact of treatment with the Chordate System S020 (medical device) on acute migraine headache pain.NCT02185703·Tübingen, Baden-Wurttemberg and 8 others

CompletedEfficacy and Safety Study of BOTOX® Compared to Topiramate for the Prevention of Chronic Migraine in AdultsThis study will evaluate the efficacy, safety and tolerability of prophylactic (preventative) treatment with BOTOX® (onabotulinumtoxinA) compared to topiramate in adults with…NCT02191579·Phoenix, Arizona and 31 others

CompletedEfficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine PreventionThis study will evaluate the safety and tolerability of the following doses of atogepant (AGN-241689): 10 mg once daily (QD), 30 mg QD, 30 mg twice daily (BID), 60 mg QD, and 60…NCT02848326·Birmingham, Alabama and 74 others

PreviousPage 67 of 91Next